Study raises new possibilities of treating depression with magic mushroom compound
Psilocybin appears to be capable of reducing depressive symptoms in patients, but scientists say more investigation needed, reports Samuel Lovett
Scientists are hopeful that a psychedelic compound unique to magic mushrooms could one day be used to treat people suffering from depression, after a new study showed it performed at least as effectively as a leading antidepressant currently prescribed to patients.
Researchers at Imperial College London found that psilocybin, a powerful hallucinogen that has similar effects to LSD, was capable of treating people with moderate-to-severe depression when combined with therapeutic support.
In a phase-two trial of 59 patients, the psychedelic was compared with an antidepressant called escitalopram, and worked more quickly in reducing self-reported depression scores.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies